COLCHICINA IASIS 0.25mg / ml oral solution medication leaflet

M04AC01 colchicine • Musculo-skeletal system | Antigout preparations | Preparations with no effect on uric acid metabolism

Colchicine is a medication primarily used for the treatment and prevention of acute gout attacks and for managing familial Mediterranean fever. It works by reducing inflammation caused by the deposition of uric acid crystals in the joints, without affecting uric acid levels in the blood.

Colchicine is taken orally, and the dosage must be carefully adjusted to avoid toxicity. It is also used in other inflammatory conditions, such as recurrent pericarditis.

Side effects may include nausea, diarrhea, abdominal pain, or, in rare cases, severe toxicity manifested as bone marrow suppression, kidney failure, or muscle damage. It is contraindicated in patients with severe renal or hepatic impairment and should be used cautiously in those taking other medications that interact with colchicine.

General data about COLCHICINA IASIS 0.25mg / ml

Substance: colchicine

Date of last drug list: 01-02-2025

Commercial code: W70849002

Concentration: 0.25mg / ml

Pharmaceutical form: oral solution

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA

Holder: IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA

Number: 15765/2025/02

Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-3 months

Pharmaceutical forms available for colchicine

Concentrations available for colchicine

0.25mg/ml, 0.5mg, 1mg